Report Detail
Global RNAi for Therapeutic Market Size, Status and Forecast 2019-2025
- RnM3041123 |
- 28 February, 2019 |
- Global |
- 96 Pages |
- QYResearch |
- Other
RNA interference (RNAi) is a biological process in which RNA molecules inhibit gene expression, typically by causing the destruction of specific mRNA molecules. Historically, it was known by other names, including co-suppression, post-transcriptional gene silencing (PTGS), and quelling. Only after these apparently unrelated processes were fully understood did it become clear that they all described the RNAi phenomenon. RNAi is now known as precise, efficient, stable and better than antisense technology for gene suppression.
RNAi for Therapeutic is in the development stage and there is no use in the market. The fastest research is Clinical phrase III, Such as QP1-1007, QO1-1002 of Quark Pharmaceuticals. The major technology of RNAi for Therapeutic is siRNA, miRNA and shRNA. SiRNA technology is the most popular, with the expenses market share of 85%, following SiRNA, miRNA is the second of 16% expenses market share in 2015.
At present, global expenses concentrates in US and Europe, US takes 80% market share and Europe takes 5% market share. There is A Few R & D Company in the world and the market concentration is high. The top5 (expenses in RNAi for Therapeutic) companies are Alnylam Pharmaceuticals, Arrowhead, Dicerna Pharmaceuticals, Gradalis, miRagen Therapeutics. The five companies occupy about 83% of the market share.
In 2018, the global RNAi for Therapeutic market size was 990 million US$ and it is expected to reach 5200 million US$ by the end of 2025, with a CAGR of 23.1% during 2019-2025.
This report focuses on the global RNAi for Therapeutic status, future forecast, growth opportunity, key market and key players. The study objectives are to present the RNAi for Therapeutic development in United States, Europe and China.
The key players covered in this study
Alnylam Pharmaceuticals
Arbutus Biopharma (Tekmira)
Arrowhead
Dicerna Pharmaceuticals
Mirna Therapeutics
Quark Pharmaceuticals
RXi Pharmaceuticals
Silence Therapeutics
Benitec Biopharma
miRagen Therapeutics
Sylentis
Gradalis
Sirnaomics
Silenseed
Market segment by Type, the product can be split into
siRNA
miRNA
shRNA
Market segment by Application, split into
Cancer
Cardiovascular
HBV
Other
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global RNAi for Therapeutic status, future forecast, growth opportunity, key market and key players.
To present the RNAi for Therapeutic development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of RNAi for Therapeutic are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered
- 1.4 Market Analysis by Type
- 1.4.1 Global RNAi for Therapeutic Market Size Growth Rate by Type (2014-2025)
- 1.4.2 siRNA
- 1.4.3 miRNA
- 1.4.4 shRNA
- 1.5 Market by Application
- 1.5.1 Global RNAi for Therapeutic Market Share by Application (2014-2025)
- 1.5.2 Cancer
- 1.5.3 Cardiovascular
- 1.5.4 HBV
- 1.5.5 Other
- 1.6 Study Objectives
- 1.7 Years Considered
2 Global Growth Trends
- 2.1 RNAi for Therapeutic Market Size
- 2.2 RNAi for Therapeutic Growth Trends by Regions
- 2.2.1 RNAi for Therapeutic Market Size by Regions (2014-2025)
- 2.2.2 RNAi for Therapeutic Market Share by Regions (2014-2019)
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Opportunities
3 Market Share by Key Players
- 3.1 RNAi for Therapeutic Market Size by Manufacturers
- 3.1.1 Global RNAi for Therapeutic Revenue by Manufacturers (2014-2019)
- 3.1.2 Global RNAi for Therapeutic Revenue Market Share by Manufacturers (2014-2019)
- 3.1.3 Global RNAi for Therapeutic Market Concentration Ratio (CR5 and HHI)
- 3.2 RNAi for Therapeutic Key Players Head office and Area Served
- 3.3 Key Players RNAi for Therapeutic Product/Solution/Service
- 3.4 Date of Enter into RNAi for Therapeutic Market
- 3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
- 4.1 Global RNAi for Therapeutic Market Size by Type (2014-2019)
- 4.2 Global RNAi for Therapeutic Market Size by Application (2014-2019)
5 United States
- 5.1 United States RNAi for Therapeutic Market Size (2014-2019)
- 5.2 RNAi for Therapeutic Key Players in United States
- 5.3 United States RNAi for Therapeutic Market Size by Type
- 5.4 United States RNAi for Therapeutic Market Size by Application
6 Europe
- 6.1 Europe RNAi for Therapeutic Market Size (2014-2019)
- 6.2 RNAi for Therapeutic Key Players in Europe
- 6.3 Europe RNAi for Therapeutic Market Size by Type
- 6.4 Europe RNAi for Therapeutic Market Size by Application
7 China
- 7.1 China RNAi for Therapeutic Market Size (2014-2019)
- 7.2 RNAi for Therapeutic Key Players in China
- 7.3 China RNAi for Therapeutic Market Size by Type
- 7.4 China RNAi for Therapeutic Market Size by Application
8 Japan
- 8.1 Japan RNAi for Therapeutic Market Size (2014-2019)
- 8.2 RNAi for Therapeutic Key Players in Japan
- 8.3 Japan RNAi for Therapeutic Market Size by Type
- 8.4 Japan RNAi for Therapeutic Market Size by Application
9 Southeast Asia
- 9.1 Southeast Asia RNAi for Therapeutic Market Size (2014-2019)
- 9.2 RNAi for Therapeutic Key Players in Southeast Asia
- 9.3 Southeast Asia RNAi for Therapeutic Market Size by Type
- 9.4 Southeast Asia RNAi for Therapeutic Market Size by Application
10 India
- 10.1 India RNAi for Therapeutic Market Size (2014-2019)
- 10.2 RNAi for Therapeutic Key Players in India
- 10.3 India RNAi for Therapeutic Market Size by Type
- 10.4 India RNAi for Therapeutic Market Size by Application
11 Central & South America
- 11.1 Central & South America RNAi for Therapeutic Market Size (2014-2019)
- 11.2 RNAi for Therapeutic Key Players in Central & South America
- 11.3 Central & South America RNAi for Therapeutic Market Size by Type
- 11.4 Central & South America RNAi for Therapeutic Market Size by Application
12 International Players Profiles
- 12.1 Alnylam Pharmaceuticals
- 12.1.1 Alnylam Pharmaceuticals Company Details
- 12.1.2 Company Description and Business Overview
- 12.1.3 RNAi for Therapeutic Introduction
- 12.1.4 Alnylam Pharmaceuticals Revenue in RNAi for Therapeutic Business (2014-2019)
- 12.1.5 Alnylam Pharmaceuticals Recent Development
- 12.2 Arbutus Biopharma (Tekmira)
- 12.2.1 Arbutus Biopharma (Tekmira) Company Details
- 12.2.2 Company Description and Business Overview
- 12.2.3 RNAi for Therapeutic Introduction
- 12.2.4 Arbutus Biopharma (Tekmira) Revenue in RNAi for Therapeutic Business (2014-2019)
- 12.2.5 Arbutus Biopharma (Tekmira) Recent Development
- 12.3 Arrowhead
- 12.3.1 Arrowhead Company Details
- 12.3.2 Company Description and Business Overview
- 12.3.3 RNAi for Therapeutic Introduction
- 12.3.4 Arrowhead Revenue in RNAi for Therapeutic Business (2014-2019)
- 12.3.5 Arrowhead Recent Development
- 12.4 Dicerna Pharmaceuticals
- 12.4.1 Dicerna Pharmaceuticals Company Details
- 12.4.2 Company Description and Business Overview
- 12.4.3 RNAi for Therapeutic Introduction
- 12.4.4 Dicerna Pharmaceuticals Revenue in RNAi for Therapeutic Business (2014-2019)
- 12.4.5 Dicerna Pharmaceuticals Recent Development
- 12.5 Mirna Therapeutics
- 12.5.1 Mirna Therapeutics Company Details
- 12.5.2 Company Description and Business Overview
- 12.5.3 RNAi for Therapeutic Introduction
- 12.5.4 Mirna Therapeutics Revenue in RNAi for Therapeutic Business (2014-2019)
- 12.5.5 Mirna Therapeutics Recent Development
- 12.6 Quark Pharmaceuticals
- 12.6.1 Quark Pharmaceuticals Company Details
- 12.6.2 Company Description and Business Overview
- 12.6.3 RNAi for Therapeutic Introduction
- 12.6.4 Quark Pharmaceuticals Revenue in RNAi for Therapeutic Business (2014-2019)
- 12.6.5 Quark Pharmaceuticals Recent Development
- 12.7 RXi Pharmaceuticals
- 12.7.1 RXi Pharmaceuticals Company Details
- 12.7.2 Company Description and Business Overview
- 12.7.3 RNAi for Therapeutic Introduction
- 12.7.4 RXi Pharmaceuticals Revenue in RNAi for Therapeutic Business (2014-2019)
- 12.7.5 RXi Pharmaceuticals Recent Development
- 12.8 Silence Therapeutics
- 12.8.1 Silence Therapeutics Company Details
- 12.8.2 Company Description and Business Overview
- 12.8.3 RNAi for Therapeutic Introduction
- 12.8.4 Silence Therapeutics Revenue in RNAi for Therapeutic Business (2014-2019)
- 12.8.5 Silence Therapeutics Recent Development
- 12.9 Benitec Biopharma
- 12.9.1 Benitec Biopharma Company Details
- 12.9.2 Company Description and Business Overview
- 12.9.3 RNAi for Therapeutic Introduction
- 12.9.4 Benitec Biopharma Revenue in RNAi for Therapeutic Business (2014-2019)
- 12.9.5 Benitec Biopharma Recent Development
- 12.10 miRagen Therapeutics
- 12.10.1 miRagen Therapeutics Company Details
- 12.10.2 Company Description and Business Overview
- 12.10.3 RNAi for Therapeutic Introduction
- 12.10.4 miRagen Therapeutics Revenue in RNAi for Therapeutic Business (2014-2019)
- 12.10.5 miRagen Therapeutics Recent Development
- 12.11 Sylentis
- 12.12 Gradalis
- 12.13 Sirnaomics
- 12.14 Silenseed
13 Market Forecast 2019-2025
- 13.1 Market Size Forecast by Regions
- 13.2 United States
- 13.3 Europe
- 13.4 China
- 13.5 Japan
- 13.6 Southeast Asia
- 13.7 India
- 13.8 Central & South America
- 13.9 Market Size Forecast by Product (2019-2025)
- 13.10 Market Size Forecast by Application (2019-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.1.1 Research Programs/Design
- 15.1.1.2 Market Size Estimation
- 12.1.1.3 Market Breakdown and Data Triangulation
- 15.1.2 Data Source
- 15.1.2.1 Secondary Sources
- 15.1.2.2 Primary Sources
- 15.1.1 Methodology/Research Approach
- 15.2 Disclaimer
Summary:
Get latest Market Research Reports on RNAi for Therapeutic . Industry analysis & Market Report on RNAi for Therapeutic is a syndicated market report, published as Global RNAi for Therapeutic Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of RNAi for Therapeutic market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
